23 results on '"Hui, David S."'
Search Results
2. Role of fomites in SARS transmission during the largest hospital outbreak in Hong Kong.
- Author
-
Xiao, Shenglan, Li, Yuguo, Wong, Tze-wai, and Hui, David S. C.
- Subjects
SARS disease ,DISEASE outbreaks ,PARAMETER estimation ,DISEASE reservoirs (Public health) - Abstract
The epidemic of severe acute respiratory syndrome (SARS) had a significant effect on global society in the early 2000s and the potential of its resurgence exists. Studies on the modes of transmission of SARS are limited though a number of outbreak studies have revealed the possible airborne route. To develop more specific and effective control strategies, we conducted a detailed mechanism-based investigation that explored the role of fomite transmission in the well-known Ward 8A outbreak. We considered three hypothetical transmission routes, i.e., the long-range airborne, fomite and combined routes, in 1,744 scenarios with combinations of some important parameters. A multi-agent model was used to predict the infection risk distributions of the three hypothetical routes. Model selection was carried out for different scenarios to compare the distributions of infection risk with that of the reported attack rates and select the hypotheses with the best fitness. Our results reveal that under the assumed conditions, the SARS coronavirus was most possible to have spread via the combined long-range airborne and fomite routes, and that the fomite route played a non-negligible role in the transmission. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
3. Severe acute respiratory syndrome and other emerging severe respiratory viral infections.
- Author
-
Hui, David S. and Peiris, Malik
- Subjects
- *
SARS disease , *H7N9 Influenza , *VIRUS diseases , *RESPIRATORY infections , *MIDDLE East respiratory syndrome , *HEALTH facilities - Abstract
The article offers information on the severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) along with other severe respiratory viral infections. Topics discussed include SARS-coronavirus that first emerged in November, 2002 in Foshan, China, where many healthcare workers became infected; spread of the virus through respiratory droplets and contact with fomite; and the nosocomial transmission that was common during 2013–2016.
- Published
- 2019
- Full Text
- View/download PDF
4. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status.
- Author
-
NGAI, Jenny C., KO, Fanny W., NG, Susanna S., Kin-Wang TO, Mabel TONG, and HUI, David S.
- Subjects
SARS disease ,PULMONARY function tests ,HEALTH surveys ,MEDICAL care ,HEALTH - Abstract
Background and objective: Severe acute respiratory syndrome (SARS) emerged in 2003 and its long-term sequelae remain largely unclear. This study examined the long-term outcome of pulmonary function, exercise capacity, health and work status among SARS survivors. Methods: A prospective cohort study of SARS patients at the Prince of Wales Hospital, Hong Kong was conducted, with serial assessments of lung function, 6MWD and 36 item Short Form General Health Survey at 3, 6, 12, 18 and 24 months after disease onset. The work status was also recorded. Results: Serial assessments were completed by 55 of the 123 (39.9%) subjects, of whom 27 were health-care workers (HCW). The mean age of the group was 44.4 (SD 13.2) years and 19 (34.5%) were males. At 24 months, 10 (18.2%), 9 (16.4%), 6 (10.9%) and 29 (52.7%) subjects had FEV
1 , FVC, TLC and DLCO < 80% of predicted values, respectively. The mean (SD) 6MWD increased significantly from 439.0 (89.1) m at 3 months to 460.1 (102.8) m at 6 months ( P 0.016) and became steady after 6 months. However, 6MWD and 36 item Short Form General Health Survey scores were lower than the normal population throughout the study. Moreover, 29.6% of HCW and 7.1% of non-HCW had not returned to work 2 years after illness onset. Conclusions: This 2-year study of a selected population of SARS survivors, showed significant impairment of DLCO , exercise capacity and health status persisted, with a more marked adverse impact among HCW. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
5. Why Did Outbreaks of Severe Acute Respiratory Syndrome Occur in Some Hospital Wards but Not in Others?
- Author
-
Yu, Ignatius T., Zhan Hong Xie, Tsoi, Kelvin K., Yuk Lan Chiu, Siu Wai Lok, Xiao Ping Tang, Hui, David S., Lee, Nelson, Yi Min Li, Zhi Tong Huang, Tao Liu, Tze Wai Wong, Nan Shan Zhong, and Sung, Joseph J.
- Subjects
SARS disease ,HOSPITAL wards ,NURSES ,MEDICAL records ,REGRESSION analysis ,OXYGEN therapy ,RESPIRATORY infections ,SUPERSPREADING events - Abstract
Background. Most documented "superspreading events" of severe acute respiratory syndrome (SARS) occurred in hospitals, but the underlying causes remain unclear. We systematically analyzed the risk factors for nosocomial outbreaks of SARS among hospital wards in Guangzhou and Hong Kong, China. Methods. A case-control study was conducted. Case wards were hospital wards in which superspreading events of SARS occurred, and control wards were wards in which patients with SARS were admitted, but no subsequent nosocomial outbreaks occurred. Information on environmental and administrative factors was obtained through visits to the wards and interviews with ward managers or nursing officers. Relevant information about host factors was abstracted from the medical records. Logistic regression analyses were used to identify the major risk factors for superspreading events. Results. Eighty-six wards in 21 hospitals in Guangzhou and 38 wards in 5 hospitals in Hong Kong were included in the study. Six risk factors were significant in the final multiple-logistic regression model: minimum distance between beds of ⩽1 m (odds ratio [OR], 6.94; 95% confidence interval [CI], 1.68-28.75), availability of washing or changing facilities for staff (OR, 0.12; 95% CI, 0.02-0.97), whether resuscitation was ever performed in the ward (OR, 3.81; 95% CI, 1.04-13.87), whether staff members worked while experiencing symptoms (OR, 10.55; 95% CI, 2.28-48.87), whether any host patients (index patient or the first patient with SARS admitted to a ward) required oxygen therapy (OR, 4.30; 95% CI, 1.00-18.43), and whether any host patients required bi-level positive airway pressure ventilation (OR, 11.82; 95% CI, 1.97-70.80). Conclusions. Our results revealed that factors that were associated with the ward environment and administration were important in nosocomial outbreaks of SARS. The lessons learned from this study remain very important and highly relevant to the daily operation of hospital wards if we are to prevent nosocomial outbreaks of other respiratory infections in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
6. Toning down the 2019-nCoV media hype—and restoring hope.
- Author
-
Ippolito, Giuseppe, Hui, David S, Ntoumi, Francine, Maeurer, Markus, and Zumla, Alimuddin
- Subjects
COVID-19 ,MASS media ,EMERGING infectious diseases ,MIDDLE East respiratory syndrome ,SARS disease - Published
- 2020
- Full Text
- View/download PDF
7. Anti -- Severe Acute Respiratory Syndrome Coronavirus Immune Responses: The Role Played by Vγ9Vδ2 T Cells.
- Author
-
Poccia, Fabrizio, Agrati, Chiara, Castilletti, Concetta, Bordi, Licia, Gioia, Cristiana, Horejsh, Douglas, Ippolito, Giuseppe, Chan, Paul K. S., Hui, David S. C., Sung, Joseph J. Y., Capobianchi, Maria Rosaria, and Malkovsky, Miroslav
- Subjects
SARS disease ,IMMUNOGLOBULIN G ,IMMUNE response ,T cells ,EPIDEMICS - Abstract
Severe acute respiratory syndrome (SARS) is caused by a novel coronavirus (SARS-CoV) strain. Analyses of T cell repertoires in health care workers who survived SARS-CoV infection during the 2003 outbreak revealed that their effector memory Vγ9Vδ2 T cell populations were selectively expanded ~3 months after the onset of disease. No such expansion of their αβ T cell pools was detected. The expansion of the Vγ9Vβ2 T cell population was associated with higher anti-SARS-CoV immunoglobulin G titers. In addition, in vitro experiments demonstrated that stimulated Vγ9Vδ2 T cells display an interferon-γ-dependent anti-SARS-CoV activity and are able to directly kill SARS-CoV-infected target cells. These findings are compatible with the possibility that Vγ9Vδ2 T cells play a protective role during SARS. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
8. The 1-Year Impact of Severe Acute Respiratory Syndrome on Pulmonary Function, Exercise Capacity, and Quality of Life in a Cohort of Survivors.
- Author
-
Hui, David S., Wong, Ka T., Ko, Fanny W., Tam, Lai S., Chan, Doris P., Jean Woo, and Sung, Joseph J. Y.
- Subjects
- *
SARS disease , *QUALITY of life , *EXERCISE , *LUNGS , *HOSPITAL care , *INFECTION , *VIRUSES - Abstract
This article presents information on a study which examines pulmonary function, exercise capacity, and health-related quality of life among severe acute respiratory syndrome (SARS) survivors. The emergence of SARS in Southern China in November 2002, followed by the global outbreak in 2003, caught the medical profession by surprise. Studies on SARS-coronavirus viral loads have shown that peak viral levels were reached at the second week of illness when patients were receiving hospital care, and thus health-care workers were particularly prone to infection while caring for their patients. The morbidity of SARS is highlighted by the observation that even when there was only 10% of total lung field involved by consolidation, 50% of patients would require supplemental oxygen in order to maintain oxygen saturation > 90%.
- Published
- 2005
- Full Text
- View/download PDF
9. Absence of association between angiotensin converting enzyme polymorphism and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome: a case control study.
- Author
-
Chan, K. C. Allen, Tang, Nelson L. S., Hui, David S. C., Chung, Grace T. Y., Wu, Alan K. L., Chim, Stephen S. C., Chiu, Rossa W. K., Lee, Nelson, Choi, K. W., Sung, Y. M., Chan, Paul K. S., Tong, Y. K., Lai, S. T., Yu, W. C., Owen Tsang, and Dennis Lo, Y. M.
- Subjects
SARS disease ,ANGIOTENSIN converting enzyme ,RESPIRATORY distress syndrome ,CORONAVIRUS diseases ,HYPOXEMIA ,PATIENTS - Abstract
Background: It has been postulated that genetic predisposition may influence the susceptibility to SARScoronavirus infection and disease outcomes. A recent study has suggested that the deletion allele (D allele) of the angiotensin converting enzyme (ACE) gene is associated with hypoxemia in SARS patients. Moreover, the ACE D allele has been shown to be more prevalent in patients suffering from adult respiratory distress syndrome (ARDS) in a previous study. Thus, we have investigated the association between ACE insertion/deletion (I/D) polymorphism and the progression to ARDS or requirement of intensive care in SARS patients. Method: One hundred and forty genetically unrelated Chinese SARS patients and 326 healthy volunteers were recruited. The ACE I/D genotypes were determined by polymerase chain reaction and agarose gel electrophoresis. Results: There is no significant difference in the genotypic distributions and the allelic frequencies of the ACE I/ D polymorphism between the SARS patients and the healthy control subjects. Moreover, there is also no evidence that ACE I/D polymorphism is associated with the progression to ARDS or the requirement of intensive care in the SARS patients. In multivariate logistic analysis, age is the only factor associated with the development of ARDS while age and male sex are independent factors associated with the requirement of intensive care. Conclusion: The ACE I/D polymorphism is not directly related to increased susceptibility to SARS-coronavirus infection and is not associated with poor outcomes after SARS-coronavirus infection. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
10. Treatment of severe acute respiratory syndrome.
- Author
-
Hui, David S. C., Sung, Joseph J. T., and Sung, Joseph J Y
- Subjects
- *
SARS disease , *CORONAVIRUS diseases , *VIRAL genomes , *GENE mapping , *GENETIC techniques , *RESPIRATORY insufficiency , *THERAPEUTICS , *LUNG diseases - Abstract
Focuses on issues and topics related to severe acute respiratory syndrome (SARS). Comparison on the genetic analysis of the SARS coronavirus isolates from Guangzhou with other strains in other countries; Development of respiratory failure as the major complication of SARS; Impact of the limited knowledge about this newly emerged disease on efforts of health experts to develop a cure.
- Published
- 2004
- Full Text
- View/download PDF
11. Laboratory Diagnosis of SARS.
- Author
-
Chan, Paul K.S., Wing-Kin To, King-Cheung Ng, Lam, Rebecca K. Y., Tak-Keung Ng, Chan, Rickjason C. W., Wu, Alan, Wai-Cho Yu, Lee, Nelson, Hui, David S. C., Sik-To Lai, Hon, Ellis K. L., Chi-Kong Li, Sung, Joseph J. Y., and Tam, John S.
- Subjects
SARS disease ,DIAGNOSTIC virology ,CLINICAL pathology ,EMERGING infectious diseases ,COMMUNICABLE diseases - Abstract
The virologic test results of 415 patients with severe acute respiratory syndrome (SARS) were examined. The peak detection rate for SARS-associated coronavirus occurred at week 2 after illness onset for respiratory specimens, at weeks 2 to 3 for stool or rectal swab specimens, and at week 4 for urine specimens. The latest stool sample that was positive by reverse transcription-polymerase chain reaction (RT-PCR) was collected on day 75 while the patient was receiving intensive care. Tracheal aspirate and stool samples had a higher diagnostic yield (RT-PCR average positive rate for first 2 weeks: 66.7% and 56.5%, respectively). Pooled throat and nasal swabs, rectal swab, nasal swab, throat swab, and nasopharyngeal aspirate specimens provided a moderate yield (29.7%-40.0%), whereas throat washing and urine specimens showed a lower yield (17.3% and 4.5%). The collection procedures for stool and pooled nasal and throat swab specimens were the least likely to transmit infection, and the combination gave the highest yield for coronavirus detection by RT-PCR. Positive virologic test results in patient groups were associated with mechanical ventilation or death (p < 0.001), suggesting a correlation between viral load and disease severity. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
12. The Spectrum of Severe Acute Respiratory Syndrome--Associated Coronavirus Infection.
- Author
-
Rainer, Timothy H., Chan, Paul K. S., Ip, Margaret, Lee, Nelson, Hui, David S., Smit, DeVilliers, Wu, Alan, Ahuja, Anil T., Tam, John S., Sung, Joseph J. Y., and Cameron, Peter
- Subjects
SARS disease ,CORONAVIRUS diseases ,VIRUS diseases ,EPIDEMICS ,HOSPITAL care - Abstract
Background: Whether subclinical or atypical presentations of severe acute respiratory syndrome (SARS) occur and whether clin-ical judgment is accurate in detecting SARS are unknown. Objectives: To describe the spectrum of SARS coronavirus infec-tion in a large outbreak and to compare diagnoses based on clinical judgment with the SARS coronavirus test. Design: Secondary analysis of prospectively collected clinical data and archived serum. Setting: A SARS screening clinic of a university hospital in the New Territories of Hong Kong. Patients: 1221 patients attending the clinic between 12 March 2003 and 12 May 2003. Measurements: SARS coronavirus serology. Results: 145 of 553 (26%) patients had serologic evidence of SARS coronavirus infection. Of 910 patients who were managed without hospitalization, only 6 had serologic evidence of SARS Five of the six patients had normal chest radiographs, and four had symptoms such as myalgia, chills, coughing, and feeling feverish. With the SARS coronavirus serologic test as the gold standard, the clinical diagnosis of probable SARS at hospitalization had a sensitivity of 0.96 (95% CI, 0.91 to 0.98) and a specificity of 0.96 (CI, 0.92 to 0.97). Limitations: Follow-up serologic samples were not obtained from almost half of the patients because they declined further testing. Some people living in the community who were infected but who had minor or no symptoms might not have visited the clinic. Conclusions: There is little evidence of widespread subclinical or mild forms of SARS coronavirus infection. Clinical diagnoses during the outbreak were reasonable and resulted in appropriate triaging. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
13. Short-term outcome of critically ill patients with severe acute respiratory syndrome.
- Author
-
Gomersall, Charles D., Joynt, Gavin M., Lam, Philip, Li, Thomas, Yap, Florence, Lam, Doris, Buckley, Thomas A., Sung, Joseph J. Y., Hui, David S., Antonio, Gregory E., Ahuja, Anil T., and Leung, Patricia
- Subjects
CRITICAL care medicine ,INTENSIVE care units ,ANTIVIRAL agents ,THERAPEUTICS ,ADRENOCORTICAL hormones ,ANTI-infective agents ,SARS treatment ,SARS diagnosis ,ANALYSIS of variance ,APACHE (Disease classification system) ,ARTIFICIAL respiration ,HEALTH status indicators ,NONPARAMETRIC statistics ,PROGNOSIS ,SARS disease ,TREATMENT effectiveness ,RETROSPECTIVE studies ,RESPIRATORY mechanics - Abstract
Objective: To document the outcome and determine prognostic factors for patients with severe acute respiratory syndrome who require admission to an intensive care unit.Design: Observational cohort study involving retrospective analysis of demographic, clinical, laboratory and radiological data.Setting: Adult intensive care unit in a tertiary referral university hospital involved in a major outbreak of severe acute respiratory syndrome (SARS).Patients: The first 54 patients admitted with SARS to an intensive care unit (ICU). All were treated with corticosteroids, ribavirin, broad spectrum antimicrobials and supportive therapy.Interventions: None.Measurements and Results: All patients were admitted for respiratory failure. The median APACHE II score was 11 (interquartile range 8-13). At 28 days 34 patients (63%; 95% CI 49.6-74.6) were alive and not mechanically ventilated. Six patients were alive but ventilated (11.3%; 95% confidence interval 5.3-22.6) and 14 had died (25.9%; CI 16.1-38.9). Seven of 27 ventilated patients developed evidence of barotrauma (25.9%; 95% CI 13.2-44.7). Median maximal multiple-organ dysfunction score was 5 (interquartile range 3.3-9). Median maximal respiratory dysfunction score was 3 (interquartile range 3-4). Increased age, severity of illness, lymphocyte count, decreased steroid dose, positive fluid balance, chronic disease or immunosuppression and nosocomial sepsis were associated with poor outcome on univariate analysis. Poor outcome was defined as death or need for mechanical ventilation at 28 days after ICU admission.Conclusions: Mortality amongst critically ill patients with SARS is high. It causes predominantly severe respiratory failure, with little other organ failure, and a high incidence of barotrauma amongst those requiring mechanical ventilation. [ABSTRACT FROM AUTHOR]- Published
- 2004
- Full Text
- View/download PDF
14. Human Metapneumovirus Detection in Patients with Severe Scute Respiratory Syndrome.
- Author
-
Chan, Paul K. S., Tam, John S., Ching-Wann Lam, Chan, Edward, Wu, Alan, Chi-Kong Li, Buckley, Thomas A., King-Cheung Ng, Joynt, Gavin M., Cheng, Frankie W. T., Ka-Fai To, Lee, Nelson, Hui, David S. C., Cheung, Jo L. K., Ida Chu, Liu, Esther, Chung, Sydney S. C., and Sung, Joseph J. Y.
- Subjects
VIRUSES ,SARS disease ,RESPIRATORY infections ,MOBILE genetic elements ,MICROORGANISMS - Abstract
Presents a study that described the detection of human metapneumovirus (HMPV) in patients with severe acute respiratory distress syndrome (SARS). Methodology; Distribution of HMPV reverse transcription-polymerase chain reaction results among 25 positive nasopharyngeal aspirates; Early cytopathic effect of HMPV in rhesus monkey kidney.
- Published
- 2003
- Full Text
- View/download PDF
15. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis.
- Author
-
Wong, Raymond S M, Wu, Alan, To, K F, Lee, Nelson, Lam, Christopher W K, Wong, C K, Chan, Paul K S, Ng, Margaret H L, Yu, L M, Hui, David S, Tam, John S, Cheng, Gregory, and Sung, Joseph J Y
- Subjects
SARS disease ,RESPIRATORY infections ,THROMBOCYTOSIS ,LACTATE dehydrogenase ,DISSEMINATED intravascular coagulation ,BLOOD coagulation disorders - Abstract
Abstract Objectives: To evaluate the haematological findings of patients with severe acute respiratory syndrome (SARS). Design: Analysis of the demographic, clinical, and laboratory characteristics of patients with SARS. Setting: Prince of Wales Hospital, Hong Kong. Subjects: All patients with a diagnosis of SARS between 11 March and 29 March 2003 who had no pre-existing haematological disorders. Main outcome measures: Clinical end points included the need for intensive care and death. Univariate and multivariate analyses were performed to examine factors associated with adverse outcome. Results: 64 male and 93 female patients were included in this study. The most common findings included lymphopenia in 153 (98%) of the 157 patients, neutrophilia in 199 (82%), thrombocytopenia in 87 patients (33%), followed by thrombocytosis in 77 (49%), and isolated prolonged activated partial thromboplastin time in 96 patients (63%). The haemoglobin count dropped by more than 20 g/1 from baseline in 95 (61%) patients. Four patients (2.5%) developed disseminated intravascular coagulation. Lymphopenia was shown in haemato-lymphoid organs at postmortem examination. Multivariate analysis showed that advanced age and a high concentration of lactate dehydrogenase at presentation were independent predictors of an adverse outcome. Subsets of peripheral blood lymphocytes were analysed in 31 patients. The counts of CD4 positive and CD8 positive T cells fell early in the course of illness. Low counts of CD4 and CD8 cells at presentation were associated with adverse outcomes. Conclusions: Abnormal haematological variables were common among patients with SARS. Lymphopenia and the depletion oft lymphocyte subsets may be associated with disease activity. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
16. Misleading Chest Radiography in a Patient with SARS.
- Author
-
Lam Chan, Wu, Alan K., Lee, Nelson L., Ka Tak Wong, and Hui, David S.
- Subjects
SARS disease ,PNEUMOCOCCAL pneumonia ,CORONAVIRUS diseases ,PHYSICIANS ,RADIOLOGY ,SYMPTOMS ,DIAGNOSIS - Abstract
We report a patient who suffered from severe acute respiratory distress syndrome (SARS) presented with an uncommon chest X-ray finding, lobar pneumonia, which was never reported. We hope that this case report can help clinicians to become more aware of various initial radiological findings of SARS. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
17. Index Patient and SARS Outbreak in Hong Kong.
- Author
-
Wong, Raymond S. M. and Hui, David S.
- Subjects
- *
SARS disease , *EMPIRICAL medicine , *DEATH rate , *RESPIRATORY diseases - Abstract
During the global outbreak of severe acute respiratory syndrome (SARS) in 2003, treatment was empiric. We report the case history of the index patient in a hospital outbreak of SARS in Hong Kong. The patient recovered after conventional antimicrobial therapy. Further studies are needed to address treatment of SARS, which has high attack and death rates. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
18. Emerging respiratory tract infections.
- Author
-
Zumla, Alimuddin, Hui, David S, Al-Tawfiq, Jaffar A, Gautret, Phillipe, McCloskey, Brian, and Memish, Ziad A
- Subjects
- *
RESPIRATORY infections , *COMMUNICABLE diseases , *PUBLIC health , *ANTI-infective agents , *SARS disease , *DRUG resistance in microorganisms - Published
- 2014
- Full Text
- View/download PDF
19. Confronting the persisting threat of the Middle East respiratory syndrome to global health security.
- Author
-
Perlman, Stanley, Azhar, Esam I, Memish, Ziad A, Hui, David S, and Zumla, Alimuddin
- Subjects
- *
MIDDLE East respiratory syndrome , *MERS coronavirus , *SARS disease , *CORONAVIRUS diseases , *CROSS-sectional method , *WORLD health , *RESEARCH funding , *LONGITUDINAL method - Published
- 2020
- Full Text
- View/download PDF
20. Middle East respiratory syndrome.
- Author
-
Maurice, John, Zumla, Alimuddin, Hui, David S, and Perlman, Stanley
- Subjects
- *
MIDDLE East respiratory syndrome , *CORONAVIRUS diseases , *SARS disease , *EBOLA virus disease , *VACCINES - Abstract
Middle East respiratory syndrome (MERS) is a highly lethal respiratory disease caused by a novel single-stranded, positive-sense RNA betacoronavirus (MERS-CoV). Dromedary camels, hosts for MERS-CoV, are implicated in direct or indirect transmission to human beings, although the exact mode of transmission is unknown. The virus was first isolated from a patient who died from a severe respiratory illness in June, 2012, in Jeddah, Saudi Arabia. As of May 31, 2015, 1180 laboratory-confirmed cases (483 deaths; 40% mortality) have been reported to WHO. Both community-acquired and hospital-acquired cases have been reported with little human-to-human transmission reported in the community. Although most cases of MERS have occurred in Saudi Arabia and the United Arab Emirates, cases have been reported in Europe, the USA, and Asia in people who travelled from the Middle East or their contacts. Clinical features of MERS range from asymptomatic or mild disease to acute respiratory distress syndrome and multiorgan failure resulting in death, especially in individuals with underlying comorbidities. No specific drug treatment exists for MERS and infection prevention and control measures are crucial to prevent spread in health-care facilities. MERS-CoV continues to be an endemic, low-level public health threat. However, the virus could mutate to have increased interhuman transmissibility, increasing its pandemic potential. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
21. Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options.
- Author
-
Zumla, Alimuddin, Memish, Ziad A, Maeurer, Markus, Bates, Matthew, Mwaba, Peter, Al-Tawfiq, Jaffar A, Denning, David W, Hayden, Frederick G, and Hui, David S
- Subjects
- *
MULTIDRUG-resistant tuberculosis , *DRUG development , *ANTI-infective agents , *SARS disease , *MERS coronavirus , *RESPIRATORY infections , *ANTIVIRAL agents , *DIAGNOSIS ,RESPIRATORY infection treatment - Abstract
Summary The emergence and spread of antimicrobial-resistant bacterial, viral, and fungal pathogens for which diminishing treatment options are available is of major global concern. New viral respiratory tract infections with epidemic potential, such as severe acute respiratory syndrome, swine-origin influenza A H1N1, and Middle East respiratory syndrome coronavirus infection, require development of new antiviral agents. The substantial rise in the global numbers of patients with respiratory tract infections caused by pan-antibiotic-resistant Gram-positive and Gram-negative bacteria, multidrug-resistant Mycobacterium tuberculosis , and multiazole-resistant fungi has focused attention on investments into development of new drugs and treatment regimens. Successful treatment outcomes for patients with respiratory tract infections across all health-care settings will necessitate rapid, precise diagnosis and more effective and pathogen-specific therapies. This Series paper describes the development and use of new antimicrobial agents and immune-based and host-directed therapies for a range of conventional and emerging viral, bacterial, and fungal causes of respiratory tract infections. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
22. Surveillance for emerging respiratory viruses.
- Author
-
Al-Tawfiq, Jaffar A, Zumla, Alimuddin, Gautret, Philippe, Gray, Gregory C, Hui, David S, Al-Rabeeah, Abdullah A, and Memish, Ziad A
- Subjects
- *
RESPIRATORY infections , *EPIDEMICS , *SARS disease , *CORONAVIRUS diseases , *EMERGENCY medical services - Abstract
Summary Several new viral respiratory tract infectious diseases with epidemic potential that threaten global health security have emerged in the past 15 years. In 2003, WHO issued a worldwide alert for an unknown emerging illness, later named severe acute respiratory syndrome (SARS). The disease caused by a novel coronavirus (SARS-CoV) rapidly spread worldwide, causing more than 8000 cases and 800 deaths in more than 30 countries with a substantial economic impact. Since then, we have witnessed the emergence of several other viral respiratory pathogens including influenza viruses (avian influenza H5N1, H7N9, and H10N8; variant influenza A H3N2 virus), human adenovirus-14, and Middle East respiratory syndrome coronavirus (MERS-CoV). In response, various surveillance systems have been developed to monitor the emergence of respiratory-tract infections. These include systems based on identification of syndromes, web-based systems, systems that gather health data from health facilities (such as emergency departments and family doctors), and systems that rely on self-reporting by patients. More effective national, regional, and international surveillance systems are required to enable rapid identification of emerging respiratory epidemics, diseases with epidemic potential, their specific microbial cause, origin, mode of acquisition, and transmission dynamics. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
23. Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome
- Author
-
Lee, Nelson, Chan, P.K.S., Ip, Margaret, Wong, Eric, Ho, Jenny, Ho, Catherine, Cockram, C.S., and Hui, David S.
- Subjects
- *
IMMUNOGLOBULINS , *SARS disease , *COHORT analysis , *DISEASES , *SERUM - Abstract
Abstract: Background: The association between a robust or depressed antibody response and clinical severity of SARS remains unknown. Objectives: To study seroconversion and the magnitude of IgG responses in a SARS cohort with different disease severities. Study design and method: A retrospective analysis of all acute and convalescent-phase sera collected from a cohort of laboratory-confirmed SARS cases. Anti-SARS-CoV IgG antibody was detected using indirect immunofluorescence technique and quantified by two-fold serial dilutions. Characteristics of patients who seroconverted “early” (
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.